Andrew Perry - 16 Aug 2021 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Chief Commercial Officer
Signature
/s/ James Stillman Hanson, attorney-in-fact
Issuer symbol
GTHX
Transactions as of
16 Aug 2021
Transactions value $
$0
Form type
4
Filing time
17 Aug 2021, 16:53:35 UTC
Next filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to buy) Award $0 +300K $0.00 300K 16 Aug 2021 Common Stock 300K $14.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest as to 25% of the shares on July 28, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.